Author

M. J. Cartwright

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Assay:metagenomics· 1 Organism:plant (other)· 1

Frequent Co-Authors

M. Super· 4 shared D. E. Ingber· 3 shared B. T. Seiler· 2 shared D. J. Mooney· 2 shared E. J. Doherty· 2 shared F. Langellotto· 2 shared A. Dinis· 1 shared A. G. Stafford· 1 shared

Activity by Year

2020-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

M. Super

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Enhancers of host immune tolerance to bacterial infection discovered using linked computational and experimental approaches

M. M. Sperry, R. Novak, V. Keshari, A. L. Dinis, M. J. Cartwright, D. M. Camacho, J.-F. Pare, M. Super, M. Levin, D. E. Ingber

The paper identifies host tolerance mechanisms to bacterial infection using a Xenopus model and multi-omics analysis, finding that metal chelators and HIF-1 agonists enhance survival.

bioRxiv · Sep 30, 2021Immunology

Harnessing Colon Chip technology to identify commensal bacteria that promote host tolerance to infection

F. S. Gazzaniga, D. Camacho, M. Wu, M. F. D. S. Palazzo, A. Dinis, F. N. Grafton, M. J. Cartwright, M. Super, D. L. Kasper, D. E. Ingber

The paper uses a microfluidic organ-on-a-chip model to identify commensal bacteria that enhance host tolerance to infection, finding Enterococcus faecium promotes tolerance.

bioRxiv · Dec 5, 2020Bioengineering

A rapidly adaptable biomaterial vaccine for SARS-CoV-2

F. Langellotto, B. T. Seiler, J. Yu, M. J. Cartwright, D. White, C. Yeager, M. Super, E. J. Doherty, D. H. Barouch, D. J. Mooney

This study develops a biomaterial vaccine using mesoporous silica rods to deliver SARS-CoV-2 antigens and adjuvants, showing rapid antibody responses and neutralizing activity.

bioRxiv · Jul 7, 2020 · PreprintImmunology

Modular biomaterials vaccine technology protects against multiple pathogens and septic shock

M. Super, E. J. Doherty, M. J. Cartwright, B. T. Seiler, D. A. White, F. Langellotto, A. G. Stafford, N. Dimitrakakis, M. Karkada, A. R. Graveline, C. L. Horgan, K. R. Lightbown, F. R. Urena, C. D. Yeager, S. A. Rifai, , D. J. Mooney

The paper introduces a modular vaccine technology (ciVAX) that protects against multiple pathogens and septic shock by using inactivated bacteria and biomaterial scaffolds.

bioRxiv · Feb 25, 2020 · PreprintImmunology